Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31


Subject: Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Solicitation Number: 36C26026Q0807
Notice Type: SRCSGT
NAICS: 621511
Notice Published: 07-02-26
Response Due: 07-10-26

Agency: Department of Veterans Affairs
Office: VETERANS AFFAIRS, DEPARTMENT OF
Contact: Hector Gonzalez, Contracting Specialists This email address is being protected from spambots. You need JavaScript enabled to view it.
Office Address: VANCOUVER, WA 98661
Place of Performance: Portland VAMC 3710 NW US Veterans Hospital Road, Portland 97239

Related Notices:
        07-02-26 SOLICIT


Click for official SAM (FBO) notice, additional information, and accompanying attachments

The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).